Picture this: A talented young slugger who's just powered his team to the World Series crown, only to find his free agency journey stretching into 2026 with a shocking new twist—even a bitter rival is eyeing him up! Bo Bichette's market has exploded with intrigue, and if you're a baseball fan, you won't want to miss how this could reshape the league. But let's dive in and unpack the full story, shall we?
Bo Bichette's path to the open market has unfolded slowly, and now, according to reporting from Jon Heyman of the New York Post, the New York Yankees have thrown their hat into the ring. This development comes at an opportune time, as the Yankees are reportedly entertaining trade offers for Jazz Chisholm Jr., which could create the perfect infield opening for Bichette to slide into. Heyman's scoop reveals that both the Los Angeles Dodgers and the Chicago Cubs have also reached out to the two-time All-Star, who is hitting the free agent scene for the first time after a seven-year stint with the Toronto Blue Jays. These heavy hitters join an already impressive roster of interested teams, including the San Francisco Giants, Seattle Mariners, Boston Red Sox, and even his former club, the Blue Jays.
Now, and this is the part most people miss, Bichette's defensive skills have been a hot topic of debate among fans and analysts alike. While he's no stranger to the All-Star nod, he's widely regarded as one of the weakest defensive shortstops in MLB. To put it simply for beginners, defensive metrics like Outs Above Average (OAA) measure how many more outs a player records compared to an average fielder in the same position. In 2025, Bichette posted a -13 OAA, and over the past five seasons, his cumulative -28 OAA ranks as the fourth-worst among MLB shortstops. But here's where it gets controversial—Bichette has openly expressed willingness to shift positions, potentially moving to second base to better suit his strengths. Imagine a player like him, who could excel at second with his bat, but critics argue it might not erase the sting of his shortstop struggles. Is this a fair compromise, or just a band-aid on a bigger issue? We'll explore more on that later.
Despite the defensive hiccups, Bichette's 2025 season was nothing short of spectacular, helping propel the Blue Jays all the way to the World Series championship. He raked with a .311 batting average, a .357 on-base percentage, and a .483 slugging percentage, launching 18 home runs and driving in 94 runs. His weighted Runs Created Plus (wRC+), which adjusts for ballpark factors and era—think of it as a scaled version of offensive production where 100 is league average—was a career-high 134. He also contributed 3.8 Wins Above Replacement (WAR), a handy stat that estimates a player's total value in wins, and maintained a robust .361 weighted On-Base Average (wOBA) over 139 games. However, a partial posterior cruciate ligament (PCL) sprain in his left knee on September 6 sidelined him for the rest of the regular season. He sat out the American League Division Series (ALDS) and the American League Championship Series (ALCS), but made a heroic return for the World Series, even if he was visibly limping. Fortunately, doctors expect him to be at full health come the start of 2026—talk about a comeback story!
Zooming out, Bichette's consistency as a hitter has been a hallmark of his career, with a .294/.337/.469 slash line that places him among the elite middle infielders in baseball. Yet, injuries have been a recurring theme. In 2023, knee and quad issues limited him to just 135 games, and 2024 saw him play only 81 games due to a nagging calf strain and a fractured right middle finger. These setbacks highlight potential red flags for any team considering a long-term commitment, especially given his defensive shortcomings. On the flip side, his standout 2025 performance has boosted his stock, and with fewer powerful infield bats available in this free agent class, he's emerged as one of the prized jewels. It's a classic risk-reward scenario: the allure of his bat versus the uncertainty of staying healthy and performing in the field.
If the Yankees do deal Chisholm, Bichette could be a fantastic addition, bringing that potent offense to a lineup desperate for infield pop. But here's the controversial angle many overlook—some argue that despite his injuries and defense, his World Series heroics and offensive prowess make him a must-sign, while others worry he might be overvalued in a market where positional versatility is king. Do you think teams like the Yankees should roll the dice on Bichette, potentially at the expense of younger talent? Is his willingness to switch to second base a savvy career move, or just avoiding the inevitable decline at short? And what about the injury concerns—does his track record scream caution, or is it just part of sports' unpredictability? We'd love to hear your take—agree or disagree, drop your thoughts in the comments below! For more MLB updates, check out the Sports Illustrated newsletter to start your day with the latest scoop.
